Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Electromate announces Electromate Automation Fair September 3, 2019 PI (Physik Instrumente) announces Dave Rego as the President of PI North American Operations January 28, 2020 How Lockheed Martin is Using Augmented Reality in Aerospace Manufacturing August 14, 2019
PI (Physik Instrumente) announces Dave Rego as the President of PI North American Operations January 28, 2020